CN102895337A - Medicine for treating gout - Google Patents
Medicine for treating gout Download PDFInfo
- Publication number
- CN102895337A CN102895337A CN201210402114XA CN201210402114A CN102895337A CN 102895337 A CN102895337 A CN 102895337A CN 201210402114X A CN201210402114X A CN 201210402114XA CN 201210402114 A CN201210402114 A CN 201210402114A CN 102895337 A CN102895337 A CN 102895337A
- Authority
- CN
- China
- Prior art keywords
- medicine
- gout
- radix
- parts
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine for treating gout. The medicine for treating the gout is prepared by taking herba lycopi, Radix Astragali, radix aconiti carmichaeli, notopterygium root, radix paeoniae alba, centipede and liquorice as raw materials. The medicine can be made into clinically used tablets, capsules, pills, particles, powder, injection or paste. The medicine disclosed by the invention has the functions of benefiting qi and nourishing blood and stimulating menstrual flow and dispelling wind, is very good in curative effect on diseases, such as the gout and the like, and is safe and reliable and has no obvious toxic and side effects in clinical use.
Description
Technical field
The present invention relates to the medicine of a treatment gout, specially refer to a kind of medicine of the treatment gout for preparing take Chinese herbal medicine as raw material, the invention still further relates to the preparation method of this medicine.
Background technology
Gout claims again " hyperuricemia ", is a kind of because of the purine metabolism obstacle, makes uric acid accumulation and the disease that causes, belongs to arthritic a kind of, claims again metabolic arthritis.The definition of gout is to have a kind of metabolism that is called the material of purine that disorder has occured in the human body, the synthetic increase of uric acid or discharge reduce, cause hyperuricemia, when serum Uric Acid Concentration is too high, uric acid namely is deposited in joint, soft tissue, cartilage and the kidney with the form of sodium salt, cause the foreign body inflammatory reaction of tissue, just be gout.In recent years, along with the change of people's mode of operation and the quickening of rhythm of life, gout should be the trend that rises year by year by the disease sickness rate, age also more and more becomes younger, kidney damage can appear in gout, according to statistics, gout patients 20 %-25 % has urate nephropathy, and the person is almost 100 % the nephropathy.It comprises gouty nephropathy, acute obstruction nephropathy and lithangiuria.So should enhance your vigilance to gout, as early as possible treatment.
The medicine of western medicine gout is more at present, because doctor trained in Western medicine is not yet fully clear to this sick mechanism, the most drug treatment is devoted to eliminate surperficial pain symptom, and these medicines and life-time service are all very large to the side effect of human body, easily recurrence usually is difficult to radical cure after the treatment.
Existing this sick Chinese medicine for the treatment of is often for a kind of specific symptom, and the reason of gout is more, does not therefore often affect therapeutic effect because do not suit the medicine to the illness.
Summary of the invention
The present invention aims to provide a kind of Chinese medicine that is applicable to multiple gout, and its therapeutic effect is good, and cost is low, and toxic and side effects is less.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by the raw material of following portions by weight:
Herba Lycopi 5-15 part, yellow Stilbene 20-30 part, Radix Aconiti Lateralis Preparata 5-15 part, Rhizoma Et Radix Notopterygii 5-15 part, Radix Paeoniae Alba 5-15 part, Scolopendra 3-8 part, Radix Glycyrrhizae 6-12 part.
The further quality proportioning of each component of medicine of the present invention is:
10 parts of Herba Lycopi, 15 parts of yellow Stilbene, 10 parts of Radix Aconiti Lateralis Preparatas, Rhizoma Et Radix Notopterygii 5-15 part, 10 parts of the Radix Paeoniae Albas, 5 parts of Scolopendras, 9 parts in Radix Glycyrrhizae.
The concrete preparation method of medicine of the present invention may further comprise the steps:
The Chinese medicine of above-mentioned mass fraction is mixed, add clear water, 0.5-1.5 hours at a simmer, after repeatedly frying in shallow oil 3 times, take out medicinal residues, marmite is put in 3 medicinal liquid mixing fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then add conventional adjuvant, make tablet, capsule, pill, granule, powder, injection or the unguentum of clinical use.
" gout " name of disease is also arranged in the Chinese medicine, and the gout that modern medicine is said also is equivalent to the diseases such as " arthralgia aggravated by cold ", " severe and migratory arthralgia ", " beriberi " of the traditional Chinese medical science.Having discussion to think outer is that YIN-cold water is wet, and modern damp is attacked people's flesh tendon; Interior by delicious food is excessive usually, the wet part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels of stopping up; Cold tie mutually strongly fragrant and heat-transformation with damp, stop skin, diseased region redness hectic fever, for a long time osteomyelitis then.All medicine reasonable compatibilities in the prescription of the present invention, complementary collaborative, dialectical treatment can hold up gas to enrich blood, and stimulates the menstrual flow and dispels the wind, and for diseases such as gouts good curative effect is arranged.
Be the actual efficacy of checking medicine of the present invention, use clinical drug treatment gout patients 100 examples of the present invention.
Gout acute stage diagnostic criteria
There is A family hemolytic streptobacteria infection history pathological changes mainly to invade the following characteristics of heart and joint before the ⒈ acute rheumatic arthritis disease and can provides discriminating:
1. teenager is common;
2. hemolytic streptococcal infection is often arranged such as pharynx class tonsillitis medical history front 1～4 week of onset;
3. often invade the joint such as knee joint shoulder elbow ankle and have the migration symmetry;
4. often with performances such as myocarditis erythema iris and subcutaneous nodule;
5. Antithemolytic streptococcus antibody raises such as ASO〉the 500U antistreptokinase〉the 80U antihyaluronidase〉128U;
6. the salicylic acid preparation for treating is effective;
Therapeutic effect statistics shows: cure 79 examples, cure rate is 79%, 16 examples that are clearly better, and total effective rate 95%, clinical test results prove, and curative effect of medication of the present invention is definite, and has no side effect, and clinical practice is safe and reliable.Drug price of the present invention is also comparatively cheap.
The specific embodiment
Prepare raw material according to following weight:
Herba Lycopi 10 kg, yellow Stilbene 15 kg, Radix Aconiti Lateralis Preparata 10 kg, Rhizoma Et Radix Notopterygii 5-15 kg, the Radix Paeoniae Alba 10 kg, Scolopendra 5 kg, Radix Glycyrrhizae 9kg.
The Chinese medicine of above-mentioned mass fraction is mixed, the clear water that adds the 30kg weight portion, 0.5-1.5 hours at a simmer, after repeatedly frying in shallow oil 3 times, take out medicinal residues, marmite is put in 3 medicinal liquid mixing fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then add conventional adjuvant, make tablet, capsule, pill, granule, powder, injection or the unguentum of clinical use.
Claims (3)
1. medicine for the treatment of gout is characterized in that described medicine is the medicament of being made by the raw material of following portions by weight:
Herba Lycopi 5-15 part, yellow Stilbene 20-30 part, Radix Aconiti Lateralis Preparata 5-15 part, Rhizoma Et Radix Notopterygii 5-15 part, Radix Paeoniae Alba 5-15 part, Scolopendra 3-8 part, Radix Glycyrrhizae 6-12 part.
2. the medicine for the treatment of gout according to claim 1 is characterized in that described medicine is the medicament of being made by the raw material of following quality proportioning:
10 parts of Herba Lycopi, 15 parts of yellow Stilbene, 10 parts of Radix Aconiti Lateralis Preparatas, Rhizoma Et Radix Notopterygii 5-15 part, 10 parts of the Radix Paeoniae Albas, 5 parts of Scolopendras, 9 parts in Radix Glycyrrhizae.
3. the preparation method for the treatment of gout medicine according to claim 1 and 2, it is characterized in that the Chinese medicine of getting above-mentioned mass fraction mixes, add clear water, 0.5-1.5 hours at a simmer, repeatedly fry in shallow oil 3 times after, take out medicinal residues, marmite is put in 3 medicinal liquid mixing to be fried in shallow oil 2-4 hours, medicinal liquid is condensed into the thick paste shape, then adds conventional adjuvant, make tablet, capsule, pill, granule, powder, injection or the unguentum of clinical use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210402114XA CN102895337A (en) | 2012-10-22 | 2012-10-22 | Medicine for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210402114XA CN102895337A (en) | 2012-10-22 | 2012-10-22 | Medicine for treating gout |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102895337A true CN102895337A (en) | 2013-01-30 |
Family
ID=47568023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210402114XA Pending CN102895337A (en) | 2012-10-22 | 2012-10-22 | Medicine for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895337A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007139887A2 (en) * | 2006-05-22 | 2007-12-06 | Cargill, Incorporated | Methods for treating bone or joint inflammation |
| CN101264191A (en) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | Medicaments assembly for hyperthermia and detoxification, stagnation tendon, and preparation thereof |
| WO2008112561A1 (en) * | 2007-03-09 | 2008-09-18 | Pfantastic Medical Research Institute, Llc | Combination therapy for alleviating pain-related conditions |
| CN101601786A (en) * | 2008-06-12 | 2009-12-16 | 孙承宽 | The manufacture method of quickly curing gout disease medicament |
| CN102091141A (en) * | 2011-01-11 | 2011-06-15 | 赵晚乐 | Medicament for treating gout and preparation method thereof |
| CN102258605A (en) * | 2010-05-27 | 2011-11-30 | 张金荣 | Medicine composition for treating gout and preparation method thereof |
-
2012
- 2012-10-22 CN CN201210402114XA patent/CN102895337A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007139887A2 (en) * | 2006-05-22 | 2007-12-06 | Cargill, Incorporated | Methods for treating bone or joint inflammation |
| WO2008112561A1 (en) * | 2007-03-09 | 2008-09-18 | Pfantastic Medical Research Institute, Llc | Combination therapy for alleviating pain-related conditions |
| CN101264191A (en) * | 2008-04-25 | 2008-09-17 | 北京中泰天和科技有限公司 | Medicaments assembly for hyperthermia and detoxification, stagnation tendon, and preparation thereof |
| CN101601786A (en) * | 2008-06-12 | 2009-12-16 | 孙承宽 | The manufacture method of quickly curing gout disease medicament |
| CN102258605A (en) * | 2010-05-27 | 2011-11-30 | 张金荣 | Medicine composition for treating gout and preparation method thereof |
| CN102091141A (en) * | 2011-01-11 | 2011-06-15 | 赵晚乐 | Medicament for treating gout and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104436009B (en) | Liver cancer medicine | |
| CN101703684B (en) | Medicament for treating allergic purpura and preparation method thereof | |
| CN102091141A (en) | Medicament for treating gout and preparation method thereof | |
| CN101406688B (en) | Compound formulation for treating rheumatic arthritis and rheumatoid arthritis | |
| CN103495048A (en) | Traditional Chinese medicine composition for treating children's aphthous stomatitis | |
| CN104189363A (en) | Traditional Chinese medicinal herb for preventing and radically treating nephropathy | |
| CN101991807A (en) | Chinese herbal compound for treating liver cancer | |
| CN101143184A (en) | Orally-administered traditional Chinese medicine for treating physique weakness type intestinal ascariasis | |
| CN103181945B (en) | The purposes of Semen Luffae | |
| CN106620604A (en) | Navel moxibustion traditional Chinese medicine composition for treating chronic diarrhea as well as preparation method and application thereof | |
| CN105726634A (en) | Traditional Chinese medicine preparation for treating rhinitis | |
| CN106728145A (en) | It is a kind of to treat Chinese and western medicinal composition of acute diarrhea and preparation method thereof | |
| CN102228624A (en) | Medicament for treating pharyngitis and preparation method thereof | |
| CN101912570B (en) | Medicinal composition for treating rheumatism and preparation method thereof | |
| CN102895337A (en) | Medicine for treating gout | |
| CN104983759A (en) | Traditional Chinese medicine composition treating diabetic nephropathy and preparing method thereof | |
| CN103251776A (en) | Traditional Chinese medicine composition for treating gout | |
| CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
| CN102085350A (en) | Medicament for treating arthritis and preparation method thereof | |
| CN103211949B (en) | Traditional Chinese medicine composition for treating gastric diseases of human body as well as preparation method and application thereof | |
| CN106913669A (en) | A kind of Chinese medicine composition for treating pancreatitis and its application | |
| CN106581468A (en) | Preparation method of traditional Chinese medicine capable of treating gastric ulcer | |
| CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
| CN105079094A (en) | Traditional Chinese medicine composition for treating hemafecia | |
| CN117860856A (en) | Therapeutic composition for hepatitis B liver fibrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130130 |